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More than 100 transcripts of various abundances and kinetic classes are expressed during phases of
productive and latent infections by herpes simplex virus (HSV) type 1. To carry out rapid global analysis of
variations in such patterns as a function of perturbation of viral regulatory genes and cell differentiation, we
have made DNA microchips containing sets of 75-mer oligonucleotides specific for individual viral transcripts.
About half of these are unique for single transcripts, while others function for overlapping ones. We have also
included probes for 57 human genes known to be involved in some aspect of stress response. The chips effi-
ciently detect all viral transcripts, and analysis of those abundant under various conditions of infection dem-
onstrates excellent correlation with known kinetics of mRNA accumulation. Further, quantitative sensitivity is
high. We have further applied global analysis of transcription to an investigation of mRNA populations in cells
infected with a mutant virus in which the essential immediate-early a27 (UL54) gene has been functionally
deleted. Transcripts expressed at 6 h following infection with this mutant can be classified into three groups:
those whose abundance is augmented (mainly immediate-early transcripts) or unaltered, those whose abun-
dance is somewhat reduced, and those where there is a significant reduction in transcript levels. These do not
conform to any particular kinetic class. Interestingly, levels of many cellular transcripts surveyed are in-
creased. The high proportion of such transcripts suggests that the a27 gene plays a major role in the early
decline in cellular gene expression so characteristic of HSV infection.
The application of robotic microarraying techniques and
laser-based image analysis has led to the development of DNA
microarrays as a powerful tool for the global analysis of tran-
scriptional responses of cells and microorganisms to perturba-
tions in their environment such as stress (23, 47). The major
source of DNA sequences for gene probes are currently cloned
fragments, often amplified by PCR, but the relatively afford-
able synthesis of oligonucleotides long enough to afford
appropriate hybrid stability and specificity (especially strand
specificity) provides another approach. The use of defined
oligonucleotide probes is especially attractive for the synthesis
of microarrays specific for large viral pathogens, and Chambers
et al. have reported a highly effective chip for global assay of
human cytomegalovirus (human herpesvirus 5) using 75-mers
(6). Indeed, this is the first description of a chip for a human
pathogen. We have used this approach to synthesize a first-
generation chip for the analysis of herpes simplex virus type 1
(HSV-1; human herpesvirus 1) of equivalent specificity and
sensitivity.
Despite HSV replication and pathogenesis being phenome-
nologically well characterized (see references 53 to 56 for re-
cent reviews emphasizing our point of view), there are plenty
of gaps remaining in our understanding of its mechanistic
basis. A rapidly resolving initial acute infection is followed by
lifelong latent infection interspersed with sporadic reactivation
episodes. HSV (as well as other herpesviruses) has a promoter-
rich genome. During infection, specific promoters mapping at
cognate genes mediate transcript expression. All data suggest
that the coordinate regulation of expression of viral transcripts
must involve the transcriptional machinery of the cell in toto.
A major factor in the control of viral gene expression is the
differential activity of promoters whose functional architecture
is, in large part, responsible for controlling access to the tran-
scriptional machinery of the cell. A second major factor in the
regulation of expression of at least some viral genes is the
alteration of posttranscriptional processing and transport of
viral transcripts mediated by the activity of the immediate-
early a27 (ICP27) gene (42, 50). In this light and in the most
general sense, regulation of HSV gene expression can be un-
derstood only in light of normal cellular transcription pro-
cesses. While viral regulatory proteins operate to drastically
alter the regulatory environment of the host cell during infec-
tion, their effects are manifest through existing cellular tran-
scription factors and enzymes. Two well-studied examples of
this fact are the initial activation of immediate-early viral reg-
ulatory genes by the potent trans activator a-TIF (UL48) in
conjunction with the action of a cellular adapter, Oct-1 (2, 58).
And, the global transcriptional activator a4 (ICP4), itself re-
lated to a cellular transcriptional activator (26), functions
through stabilization of the binding of TFIID (10).
Global analysis of viral transcription under various con-
ditions of infection will provide a powerful tool for further
analysis of the HSV transcription program. We have applied
sequence-based computer programs and our own databases to
select sets of 75-nucleotide (nt) oligonucleotide sequences within
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the HSV-1 genome (Genbank accession number NC001806)
that are specific for the expression of individual viral tran-
scripts. With an eye toward efficient synthesis of oligo(dT)-
primed cDNA from RNA isolated from infected cells and
tissues, we have probed the 52 polyadenylation sites known to
function in the viral genome. More than half of the total viral
transcripts are terminated with a unique polyadenylation site
and thus can be uniquely specified with unique oligonucleo-
tides adjacent to the polyadenylation sites. Accordingly, we
arrayed these oligonucleotide probes on glass slides to gener-
ate a first-generation HSV-1 DNA microarray (HSV-chip). We
have included a set of cellular oligonucleotide probes specific
for a number of transcripts expressed from genes involved in
cellular response pathways to provide an indicator of the re-
sponse of the cell to virus infection under the conditions sur-
veyed here.
We have used nick-translated viral DNA and cloned DNA
fragments to optimize hybridization conditions and demon-
strate the high specificity of this first-generation chip. We next
generated oligo(dT)-primed cDNA labeled with Cy3- and Cy5-
tagged fluorescent nucleoside derivatives generated from RNA
isolated from cells infected and mock infected with HSV under
various conditions, which influence the class of viral and cel-
lular genes expressed. Thus, inhibition of de novo protein
synthesis allows only expression of immediate-early genes,
blockage of DNA replication inhibits expression of strict late
genes, isolation of RNA at short times after infection results in
high enrichment of early-phase transcripts, and isolation of
RNA at a time of high rates of viral genome replication results
in preferential recovery of late transcripts. The data presented
here demonstrate that all classes of viral transcripts can be
detected with good efficiency and very high specificity. Further,
a limited set of cellular transcripts are induced following in-
fection against a general background of virus-mediated shutoff
of cellular gene expression. Measurement of the transcript
population abundant in cells infected with a mutant of HSV-1
lacking a functional a27 (UL54) gene revealed significantly
different patterns of both viral and cellular genes.
MATERIALS AND METHODS
Selection and synthesis of oligonucleotide probes for the microarray. We
followed published methodology (6, 47) to select a total of 99 individual 75-mers
specific for individual HSV-1 transcription units. The positions of these oligo-
nucleotides vis-a`-vis the sequence of the genome of HSV-1 strain 17syn1 are
shown in Table 1. Our overall criteria for choice were as follows. We concen-
trated within 300 nt of the polyadenylation [poly(A)] signal for each transcript
group because synthesis of cDNA using oligo(dT) primers with the bulky Cy3-
and Cy5-tagged dCTP produces a product of average length of less than 500 nt.
We then used the commercial Oligo6 program (Molecular Biology Insights,
Cascade, Colo.) to scan these sequences and chose 75-mers whose base compo-
sition was near the average for the region as a whole and which did not display
a large deal of self-homology that would lead to the formation of hairpin loops.
Oligonucleotides thus chosen had G1C contents ranging from 50 to 80%. Two
nonoverlapping oligomers were chosen for all abundant transcripts. Cell genes
(GenBank notation) and accession numbers from which specific oligonucleo-
tides were synthesized are as follows: ATF3, L19871; JUNC, J04111; CCNA
cyclinA, M963390; JUND, NM005354; MAPK, NM002745; MBP-2, X65644;
MHC-1, NM005514; MHC-2, AH002891; CvDC25A, NM001789; mlkBa,
L32976; CvDC25B, NM004358; NFAT1, U43341, CYCLIN B, M25753; NF-Y,
NM002505; CYCLIND1, NM001758; NF-YB, NM006166; E2F1, AH006643;
N-SHC, D84361; E2F2, NM004091; p107, NM002895; p130 HSP130K, X76061;
p15, U19796; E2F5, NM001951; p16, U12820; EGR1, NM001964; p18, J04991;
ELK, NM005229; p19, U71364; FAS-1A, D38122; p21 (PAK1), NM002576;
FAS-2, M67454; p27, NM005532; FOS, NM005252; p300, NM001429; FRA1,
NM005438; p38 (RPP38), NM006414; p53, AAF63442; p65NFkB, A42017;
RARa1, NM000964; RARb, NM000965; RXRb, AF120161; IL6, S56892;
INFa/b, M54886; SRF, NM003131; INT6, UP4175; STAT2, NM005419; IRF1,
NM002198; STAT5, NM003252; ISG 54K E1, M14659; STAT6, NM003153; ISG
54K E2, M14660; TAP1, L21207; ISG F3g p48, NM000107; JAK3,
NM000215; JNK, NM002750; JUN B, NM002229; UNG, NM003362; and JUN-
Bta, U20734.
Oligonucleotides were synthesized by using a PE Perseptive Bio-System (Fra-
mingham, Mass.) Expedite MOSS DNA synthesizer with membrane columns.
Synthesized gene target oligonucleotides were cleaved, deprotected, and purified
by standard procedures. Probe oligonucleotides were transferred in triplicate to
96-well master plates at a concentration of 1 mg/ml in 33 SSC (13 SSC is 0.15 M
NaCl plus 0.015 M sodium citrate) for robotic deposition.
TABLE 1. Locations of specific 75-mer probes on
the HSV strain 17syn1 genome
Probe set Transcriptdetecteda
Locationb
Poly(A) site Probe 1 Probe 2
R.A ICP34.5R 1535R 1397R
R.O ICPOR 5638R 5385R 5535R
R.C RHA6 5946L 6076L
R.D RLXL 7662L 7766L
R.E RLXYL 8368L 8558L
U.1 UL1/2R 10945R
c 10844R 10743R
U.1X UL1XL 9635L 9757L
U.3 UL3R 11717R 11599R 11519R
U.4 UL4/5L 11760L 11961L 11896L
U.6 UL6/7R 18037R 17915R 17840R
U.8 UL8/9L 18217L 18296L 18406L
U.10 UL10R 24645R 24544R 24407R
U.12 UL12/14L 24807L 24919L 25005L
U.15 UL15R 34820R 34624R 34743R
U.16 UL16/17L 30178L 30415L 30375L
U.18 UL18/20L 35028L 35187L 35234L
U.19X UL19/20L 36405L
d 36690L 36483L
U.21 UL21R 43690R 43485R 43611R
U.22 UL22L 43870L 43971L 44061L
U.23 UL23L 46626L 46706L 46816L
U.24 UL24R 48739R
e 48622R 48548R
U.25 UL25/26R 52766R 52681R 52571R
U.27 UL27/28L 53063L 53153L 53253L
U.29 UL29L 58414L 58513L 58529L
U.30 UL30R 66548R 66357R 66218R
U.31 UL31/34L 66382L 66460L 66594L
U.35 UL35R 70938R 70774R 70834R
U.36 UL36L 70938L 71119L 71182L
U.37 UL37L 80717L 80902L 80823L
U.38 UL38R 86016R
f 85897R 85936R
U.39 UL39/40R 90983R 90876R 90897R
U.41 UL41L 91121L 91214L 91201L
U.42 UL42R 94633R 94478R 94435R
U.43 UL43R 96063R 95948R 95837R
U.44 UL44/45R 98663R 98363R 98533R
U.46 UL46/47L 98731L 98829L 98932L
U.48 UL48L 103542L 103619L 103695L
U.49 UL49/49.5L 105467L 105545L 105620L
U.50 UL50R 108152R 107969R 108038R
U.51 UL51L 108281L 108357L 108432L
U.52 UL52/53R 113443R 113300R 113225R
U.54 UL54R 115277R 115193R 115091R
U.55 UL55R 116098R 115911R 115896R
U.56 UL56L 116201L 116341L 116282L
R.F LATAR 127141R 126776R 126450R
R.4 ICP4L 127189L 127305L 127390L
S.1 US1R 133941R 133841R 133788R
S.2 US2L 134041L 134206L 134257L
S.3 US3/4R 137508R 137383R 137433R
S.5 US5/7R 141013R 140897R 140937R
S.8 US8/9R 143667R 143514R 143592R
S.12 US10/12L 144139L 144255L 144218L
a R designates rightward transcription; i.e., the sense of the transcript is the
same sense as the prototypical genome arrangement. L designates leftward
transcription; i.e., the sense of the transcript is opposite genome sense.
b The number designates the location of the first base of each oligonucleotide
read in the sense of transcript. Therefore, probes designated R are read genome
sense left to right, and those designated L are read right to left on the comple-
mentary DNA strand.
c Differentially used at early and late times.
d Weak poly(A) site.
e Poly(A) site usage is regulated.
f Significant transcriptional read-through in some cell types.
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Generation of microarrays, hybridization, and scanning. The deposition print-
ing of DNA was carried out as described in reference 6. The microarrayer tip
delivered approximately 4 nl per spot on prescreened custom-made polylysine-
coated glass slides (46, 47; see also http://www.gene-chips.com/). Microarrays
were hybridized for 16 h in 53 SSC–0.2% sodium dodecyl sulfate (SDS) at 68°C
under coverslips with combined Cy5dCTP and Cy3dCTP (Amersham)-labeled
DNA. The entire assembly was enclosed in a custom-made hybridization cham-
ber. After hybridization, the microarray slide assembly was washed for 5 min in
13 SSC–0.2% SDS at room temperature for 5 min, 5 min in 0.13 SSC–0.2%
SDS at room temperature, and 1 min in 0.13 SSC, spun dry in a low-speed
centrifuge, and scanned. Microarrays were scanned by using a confocal laser
ScanArray 4000 (General Scanning, Inc.) system. Data were collected at a max-
imum resolution of 10 mm/pixel with 16 bits of depth by using Quantarray
software (General Scanning).
Cells and virus. We used HSV-1 (17syn1) for kinetic and control experiments.
The 27lacZ mutant, in which a b-galactosidase cassette was inserted into the a27
(UL54) gene to inactivate the protein, was constructed from the KOS strain, and
control experiments with this virus were done with the wild-type (wt) parent (40,
49, 52). Cultures of 5 3 106 HeLa cells in 100-mm2 plates were used for
infections at a multiplicity of infection of 5 PFU/cell except where indicated
otherwise. Cells were maintained at 37°C under 5% carbon dioxide in Eagle
minimum essential medium containing 5% calf serum, 100 U of penicillin per ml,
and 100 mg of streptomycin per ml.
RNA preparation, cDNA synthesis, and nick translation. We followed pub-
lished procedures (11, 12, 24, 27, 31, 47, 56) to extract total RNA from infected
and mock-infected cells. Virus was adsorbed for 30 min prior to addition of fresh
overlay medium. For preparation of RNA from cycloheximide and phosphono-
acetic acid (PAA)-treated cells, cells were pretreated with drug for 30 min prior
to addition of virus, and drug was present in the virus inocula and overlay
medium. At appropriate times, cultures were rinsed twice with ice-cold saline
containing cycloheximide (50 mg/ml), scraped and deposited by low-speed cen-
trifugation, and then extracted with guanidinium isothiocyanate. Extracted RNA
was recovered by pelleting through a 5.7 M CsCl cushion by centrifugation for
16 h at 36,000 rpm in a Beckman SW41 rotor. RNA recoveries were approxi-
mately 200 mg per dish.
Fluorescence-labeled cDNA was prepared from 40-mg aliquots of total in-
fected or mock-infected cell RNA by oligo(dT)-primed polymerization by using
SuperScript II reverse transcriptase (Gibco-BRL). The pool of nucleotides in the
labeling reaction consisted of 0.5 mM dGTP, dATP, and dTTP and 0.3 mM
dCTP and fluorescent nucleotides (Cy3dCTP and Cy5dCTP; Amersham) at 0.1
mM. All experiments with virus-infected cell RNA or nick-translated viral DNA
were carried out with the Cy3 label. Nick-translated DNA was synthesized in a
mixture of 50 mM Tris-HCl (pH 7.2), 10 mM MgSO4, and 0.1 mM dithiothreitol
with 20 mm dATP, dTTP, dGTP, and Cy3dCTP. Fluorescence-labeled DNA was
purified by chromatography through Microcon YM-30 columns (Amicon), then
heat denatured for 2 min at 100°C, and incubated 20 to 30 min at 37°C before
use. Hybridization was for 16 h at 68°C using 33 SSC–0.3% SDS under a glass
coverslip. The array area was ca. 3 cm2, and total hybridization volume was 20 ml.
RESULTS
Demonstration of hybridization specificity. We first estab-
lished probe specificity. We hybridized chips with probes ar-
rayed in triplicate with fluorescence-labeled nick-translated
HSV DNA at 65, 68, and 72°C. We found no appreciable
cross-hybridization to the cellular probes (data not shown). We
surveyed signal strength and plotted this versus G1C content
of the probe. We found 68°C to be the best overall tempera-
ture, since it provided the strongest hybridization signals with
no obvious correlation with G1C content (Fig. 1). Specificity
was further checked by hybridization with nick-translated
DNA from a plasmid in which only the high-G1C joint and
repeat regions were cloned (an XhoI/EcoRI fragment spanning
0.81 to 0.86 map units); here only the joint and repeat regions
represented in the clone provided a hybridization signal (data
not shown).
Patterns of RNA expression as a function of conditions of
infection. We isolated RNA from HeLa cells infected with
HSV-1 (5 PFU/cell) under various conditions of infection. Re-
sults of hybridization of cDNA generated from RNA isolated
from cells 3 h postinfection (p.i.) in the presence of cyclohex-
imide (50 mg/ml), 2 h p.i. with no drug, 4 h p.i. in the presence
of PAA (300 mg/ml) to inhibit viral DNA replication, and 8 h
p.i. with no drug are shown in Table 2. Each value is the
median of values from two completely separate experiments
with a total number of probes spotted per transcript unit rang-
ing from 6 to 12. No normalization between experiments was
carried out, but each group of signals was compared to mock-
infected controls, and the difference was ranked. The statistical
analysis is described in the table footnotes, and a significant
value (i.e., one showing a significant difference) was one with a
rank of #0.05.
Clearly, different individual transcripts reach their maximum
levels under different conditions of infection. These levels gen-
erally reflect the kinetics of expression of the transcripts as
determined by numerous individual Northern blot, RNase pro-
tection, and primer extension analyses carried out by us as well
as many other laboratories over the past two decades (29, 37,
45, 53, 55, 62). The statistical significances of the differences
between early (2-h) and late (8-h) hybridization patterns are
also listed in Table 2.
The average (mean) values from individual cycloheximide,
2-h, and 8-h RNA experiments are shown in Fig. 2. In the
absence of appreciable protein synthesis (the result of incuba-
tion of HeLa cells with 50 mg of cycloheximide per ml), only
the immediate-early genes a0 (ICP0), a4, UL54 (a27), US1
(a22 [ICP22]), and US12 (a47 [ICP47]) are expressed at high
levels. Low levels of the DNA polymerase transcript (UL30)
and large and small subunits of ribonucleotide reductase
(UL39/40) are discernible in this experiment; of this yield, only
the UL39/40 signal is significantly different from the mock-
infected control (P 5 0.0002). Expression of both low-abun-
FIG. 1. Demonstration of microarray specificity. The maximum hybridization signal in arbitrary (Arb) units attained with nick-translated HSV-1 DNA fluorescently
labeled with Cy3dCTP and hybridized with the probes listed in Table 1 at 68°C is plotted against the G1C content of each probe.
9918 STINGLEY ET AL. J. VIROL.
TABLE 2. Transcript abundance in HeLa cells infected with HSV-1 under various conditions
Transcript,
kinetic classb Remarks (reference[s])
c
Abundancea Rankd
Cycloheximide
RNA PAA RNA 2-h RNA 8-h RNA 2-h vs
8-h
Signal Rank Signal Rank Signal Rank Signal Rank
ICP34.5, L Neurovirulence (7, 8) 289 0.0081 1,412 0.0158 3,138 0.0002 2,075 0.0002 0.2174
ICP0, IE trans activator 5,838 0.0000e 4,321 0.0002 8,398 0.0000 8,521 0.0000 0.9556
RHA6, L 1,400 nt 39 of LAT cap (13) 189 0.0077 1,721 0.0002 775 0.0002 2,017 0.0002 0.0002
ORF-X, L Low abundance (48) 149 0.0011 1,351 0.1610 736 0.0011 2,945 0.0002 0.0002
ORF-Y, L Low abundance (48) 152 0.0160 2,021 0.0300 1,171 0.0002 4,347 0.0002 0.0011
UL1/2, L/E gL/uracil DNA glycosylase (48) 335 0.2817 5,002 0.0003 9,284 0.0000 6,786 0.0000 0.1943
UL3, L Unknown 381 0.6535 2,109 0.1197 2,393 0.0002 1,488 0.0586 0.0173
UL1X, ? Antisense to UL1, low abundance (48) 418 0.2691 1,896 0.0001 2,688 0.0000 5,028 0.0001 0.0000
UL4/5, L/E Unknown/part of helicase-primase complex 408 0.1681 1,821 0.0000 4,192 0.0000 8,868 0.0000 0.0024
UL6/7, L/? Capsid maturation/unknown 293 0.0030 2,512 0.0000 2,420 0.0000 10,248 0.0000 0.0000
UL8/9, E/E Part of helicase-primase complex/origin binding 198 0.0648 2,371 0.0000 3,623 0.0000 7,181 0.0000 0.0000
UL10, L gM 203 0.0171 2,017 0.0098 2,512 0.0001 7,956 0.0004 0.0000
UL11/14, L/E/L/L UL12 (alkaline exonuclease)/UL13 (protein
kinase)
385 0.7781 1,656 0.0000 5,209 0.0003 3,796 0.0000 0.0000
UL15, L Spliced-DNA packaging 307 0.1029 923 0.0027 2,332 0.0000 5,108 0.0000 0.0006
UL16/17, L/L Unknown/cleavage and packaging of DNA 235 0.0023 1,043 0.5028 1,827 0.0000 7,272 0.0000 0.0000
UL18/20, L/L/L VP23 (triplex)/VP5 major capsid protein/mem-
brane associated
173 0.0114 2,497 0.0003 5,373 0.0000 11,972 0.0000 0.0000
UL19/20, L/L Very weak poly(A) site (9) 266 0.0002 839 0.0059 2,671 0.0000 2,171 0.0038 0.0349
UL21, L Auxiliary virion maturation function (?) 227 0.0345 1,812 0.0001 3,703 0.0000 5,032 0.0000 0.0119
UL22, L gH 377 0.6975 2,806 0.0010 9,455 0.0003 5,178 0.0000 0.2581
UL23, E Thymidine kinase 288 0.1182 1,602 0.4043 6,230 0.0033 3,799 0.0002 0.0000
UL24, L Unknown regulated poly(A) site (18) 141 0.0440 1,321 0.0048 4,300 0.0034 5,182 0.0056 0.3674
UL25/26/26.5, L/L Capsid maturation/maturational protease/scaffold-
ing protein
248 0.0005 2,306 0.0002 4,989 0.0001 7,453 0.0000 0.0173
UL27/28, E/L gB/capsid maturation 278 0.0012 2,286 0.0000 4,270 0.0001 3,607 0.0000 0.6544
UL29, E Single-stranded DNA binding protein 277 0.0012 2,065 0.0000 3,180 0.0000 2,804 0.0651 0.9111
UL30, E DNA polymerase 1,029 0.0273 3,823 0.0002 4,308 0.0000 1,523 0.0117 0.0001
UL31/34, L/L/L/L Nuclear phosphoprotein/capsid maturation/capsid
maturation/phosphoprotein
662 0.1221 1,970 0.0000 1,961 0.0062 4,569 0.0005 0.0000
UL35, L Capsomer tips 392 0.0577 3,162 0.0000 3,249 0.0001 4,075 0.0019 0.1074
UL36, (E)/L ICP1/2 very large tegument protein (two tran-
scripts, smaller encodes partial ORF)
282 0.0002 1,332 0.0024 1,023 0.0072 6,666 0.0005 0.0000
UL37, E Tegument phosphoprotein 338 0.0102 2,259 0.0001 1,050 0.0003 4,959 0.0000 0.0000
UL38, L Efficiency of poly(A) site usage varies with cell
type (1, 15)
374 0.0014 1,881 0.0000 518 0.1206 5,818 0.0007 0.0000
UL39/40, E/E Large and small subunits of ribonucleotide
reductase
2,387 0.0002 8,781 0.0001 13,665 0.0000 8,890 0.0000 0.0357
UL41, L Virion-associated host shutoff protein 341 0.0024 2,022 0.0000 1,111 0.0036 3,217 0.0002 0.0000
UL42/UL43.5, E/L Part of helicase-primase complex/tegument (57) 256 0.0011 2,990 0.0015 3,699 0.0002 10,491 0.0001 0.0003
UL43, E(?) Unknown (5) 175 0.0029 1,955 0.0001 470 0.0037 1,453 0.7666 0.0000
UL44/45, L/L gC/virion associated 422 0.0022 3,647 0.0000 2,033 0.0001 10,352 0.0003 0.0000
UL46/47, L/L Modulates a-TIF (61) 1,137 0.2912 3,088 0.0000 4,126 0.0000 6,503 0.0000 0.1227
UL48, L a-TIF 238 0.0477 4,160 0.0000 4,731 0.0000 10,413 0.0000 0.0001
UL49/.49.5, E/L Tegument protein/unknown 399 0.0787 4,014 0.0006 4,837 0.0003 7,524 0.0000 0.1535
UL50, E dUTPase 294 0.0011 4,757 0.0000 2,557 0.0010 6,782 0.0000 0.0008
UL51, L Unknown 149 0.0118 1,661 0.0001 976 0.0096 11,146 0.0000 0.0000
UL52/53, E/L Helicase-primase complex/gK 255 0.0036 881 0.0040 722 0.1008 1,504 0.0000 0.0000
UL54, IE RNA transport/inhibition of splicing 12,696 0.0000 9,458 0.0000 11,889 0.0000 6,915 0.0000 0.0000
UL55, E? Unknown, pathogenesis (3, 38) 102 0.0000 2,184 0.0016 1,000 0.0358 2,225 0.0005 0.0000
UL56, E? Unknown, pathogenesis (3, 38) 212 0.7744 1,237 0.0052 904 0.0430 1,752 0.0040 0.0736
LAT/(OrfO/P)
poly(A) site
Reactivation/modulate ICP0, ICP22/modulate
ICP4?) (4, 32, 33, 59)
604 0.1786 1,031 0.0157 475 0.0532 1,499 0.0093 0.0002
ICP4, IE Broad-range trans activator 6,562 0.0241 3,789 0.0000 4,688 0.0008 7,626 0.0000 0.0172
US1, IE Host range 21,001 0.0000 17,356 0.0000 18,250 0.0000 12,606 0.0000 0.1714
US2, E? Unknown 380 0.7366 1,222 0.0094 2,036 0.2530 3,750 0.0001 0.0003
US3/4, E/E? Protein kinase/gG 364 0.0773 4,625 0.0003 8,562 0.0000 6,639 0.0000 0.0207
US5/6/7, E/E gJ/gD (entry)/gI (Fc binding) 443 0.1131 7,129 0.0001 12,655 0.0000 8,598 0.0000 0.0344
US8/9, E/E gE (Fc binding)/unknown 486 0.1692 11,934 0.0000 17,082 0.0000 9,113 0.0000 0.0000
US10/11/12, E/E/IE Unknown/RNA binding phosphoprotein/a47
(inhibits MHC-I presentation) (60)
13,764 0.0000 7,692 0.0001 14,381 0.0000 10,203 0.0000 0.0636
a Signal intensities were determined by calculating the median of background-subtracted values for two independent experiments based on 6 or 12 replicates. P values
reported with corresponding median values (Rank) were determined by ranking the replicate values for each sequence (n 5 6 or 12) from both mock-infected and
HSV-infected cells. The null hypothesis (P 5 1), that mock and HSV groups are identical, was tested for the ranked values instead of the background-adjusted values
by using Student’s t test with two-tail distribution and assuming unequal variance. This procedure of applying Student’s t test to the rank of the signals instead the signal
values is an approximation to the nonparametric Mann-Whitney rank test (16).
b Early mapping and kinetic data are compiled in reference 45. L, late; IE, immediate early; E, early.
c General information concerning genetic functions can be found in reference 37.
d The null hypothesis is that the 2- and 8-h signals are the same.
e P , 0.0001.
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FIG. 2. Hybridization of oligo(dT)-primed cDNA synthesized from HeLa cells under various conditions of infection to an HSV-1 specific microarray. Each panel
is based on a single experiment; a summary showing median values is shown in Table 2. (A) Hybridization of cDNA synthesized to RNA abundant in HeLa cells 3 h
following infection in the presence of cycloheximide (50 mg/ml). (B) Hybridization of cDNA synthesized to RNA abundant in HeLa cells 2 h following infection. (C)
Hybridization of cDNA synthesized to RNA abundant in HeLa cells 8 h following infection. Arb, arbitrary.
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dance transcripts was eliminated by increasing the stringency
of inhibition of protein synthesis through raising the inhibitor
concentration to 100 mg/ml (data not shown). Under these
conditions, expression of the a27 (UL54) transcript is also
markedly reduced. We also isolated RNA from rabbit skin cells
infected at the same multiplicity and incubated for 3 h in the
presence of the lower amount of inhibitor. There was no evi-
dent expression of transcripts detected by either the UL30- or
UL39/40-specific probe, but the relative expression of the a27
transcript was comparable to that seen in HeLa cells at the
same inhibitor concentration (data not shown).
The hybridization pattern due to the presence of RNA ex-
pressed at 2 h p.i. was, as expected, considerably more complex
(Fig. 2B). The relative abundance of thymidine kinase (UL23),
the early alkaline exonuclease transcript (UL12), DNA poly-
merase (UL30), a27, and many of the early transcripts of the
short unique region are evident. On the other hand, results for
8-h RNA hybridization (Fig. 2C) reveal the relative increase in
abundance of both strict late and leaky late transcripts, includ-
ing those hybridizing to the U.18 probe (containing the major
capsids [UL19]-encoding transcript), the strict late UL38 capsid
protein, and the gC- and UL45-encoding transcripts revealed
with the U.44 probe. In addition, the relative decline in abun-
dance of some early transcripts such as thymidine kinase, a27,
and DNA polymerase are notable.
While this analysis is generally consistent with the kinetic
classification of individual transcripts arrived at both by anal-
ysis of stable transcripts and by incorporation of radioactive
precursors as a measure of synthesis at a specific time or in the
presence of metabolic inhibitors, there are some notable dif-
ferences. One factor is a difference in the stability of viral
transcripts in HeLa cells compared to rabbit skin cells, where
thorough transcription studies have been carried out. For ex-
ample, we have extensively studied the properties of the pro-
moter controlling the expression of the UL37 transcript in
HSV-infected rabbit skin cells (30, 62). All data demonstrate
that this is a low-abundance early transcript controlled by a
relatively weak promoter. Despite this, the level of this tran-
script increases in HeLa cells between 2 and 8 h (Table 2).
Continuous labeling using [32P]orthophosphate experiments
demonstrated that the 3.6-kb UL37 transcript continues to
accumulate in HeLa cells (1), and we confirmed that this dif-
ference is cell based by carrying out a comparative analysis of
the ratio of cDNA generated from RNA isolated at late (7 h
p.i.) and early (3 h p.i.) times in rabbit skin cells. Here, the
abundance of this transcript declines as would be expected for
an early transcript (Table 3). Both the similarities and differ-
ences between the ratios of RNA abundance at late versus
early times following infection of HeLa and rabbit skin cells is
readily apparent when the log10 of each ratio is plotted as
shown in Fig. 3. The possible significance of other differences
is considered in Discussion.
Global analysis of viral transcripts accumulating in the
absence of the a27 gene product. The above results demon-
strate the efficiency of the HSV-1 DNA microarray for detect-
ing differential accumulation of viral transcripts as a function
of conditions of infection. We also compared the relative abun-
dance of viral transcripts in cells 6 h after infection with the
27lacZ mutant of the KOS strain of HSV-1 versus the parental
wt virus. The data in Table 4 show that there are generally
three groups of transcripts. The first group evidenced expres-
sion near or above wt levels. Thus, in the mutant infections a
total of 10 of the 52 transcript sets had a rank statistically
equivalent to the wt level (i.e., P .. 0.05), and one (ICP4) was
FIG. 2—Continued.
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present at greater than the wt level (P , 0.0001). The majority
(39 of 52) of transcript sets analyzed showed a statistically
significant reduction in abundance following infection with the
mutant virus. Of these, about half (21 of 39) were reduced by
a factor of 5 or more. As detailed in Discussion, the effects seen
are generally consistent with a number of other studies using
different approaches.
Response of selected cellular transcripts to HSV-1 infection.
As outlined in Materials and Methods, we designed the
present DNA microarray to contain selected human genes, a
number of which are expressed by transcripts known to be
responsive to perturbations of the cellular environment. Not
unexpectedly, we found that the maximum signal for most
cellular genes probed was significantly less than seen for the
viral transcripts, but the 57 genes listed in Table 5 all provided
a signal during at least one of the conditions tested that was
reproducibly above the background level seen with a control
human cytomegalovirus probe (UL124R) included as a nega-
tive control.
We first analyzed cellular mRNA abundance in HeLa cells
immediately following the 30-min virus adsorption period with
that compared to a mock-infected sample as a control for
differential efficiency of detecting the infected cell Cy3 label
versus the uninfected cell Cy5 label. This 0-h time point control
was used to establish a baseline for the expected normal level
of cellular transcript. We then analyzed cellular mRNA abun-
dance in HeLa cells at 2 and 8 h after infection with the 17syn1
strain of HSV-1. The average data from two independent ex-
periments are shown in Table 5, and the log10 of each ratio of
TABLE 4. Abundance of HSV transcripts at 6 h p.i. in cells infected with the 27lacZ mutanta
Probe
set
27lacZ KOS Mutant vs
KOS
rankb
Probe
set
27lacZ KOS Mutant vs
KOS rankSignal Rank (P) Signal Rank Signal Rank Signal Rank
R.A 784 0.0576 2,420 0.0062 0.0000c U.35 1,099 0.0001 5,026 0.0000 0.0000
R.O 6,855 0.0000 6,588 0.0000 0.8285 U.36 557 0.9017 3,232 0.0000 0.0001
R.C 473 0.8994 1,296 0.3714 0.0576 U.37 777 0.0187 3,184 0.0000 0.0000
R.D 458 0.9664 1,792 0.2447 0.0568 U.38 4,343 0.0000 6,559 0.0000 0.1080
R.E 1,014 0.0545 1,787 0.0000 0.1264 U.39 7,952 0.0000 9,303 0.0000 0.5991
U.1 4,423 0.0000 7,911 0.0000 0.0340 U.41 706 0.2629 3,255 0.0000 0.0007
U.1X 600 0.6425 1,765 0.0072 0.0452 U.42 710 0.0027 5,913 0.0000 0.0000
U.3 735 0.2103 4,675 0.0000 0.0000 U.43 723 0.2887 1,974 0.0000 0.0002
U.4 971 0.0014 6,005 0.0000 0.0000 U.44 1,512 0.0011 5,744 0.0000 0.0000
U.6 632 0.4950 6,767 0.0000 0.0000 U.46 964 0.0000 4,642 0.0000 0.0000
U.8 601 0.1233 4,505 0.0000 0.0000 U.48 909 0.0004 8,040 0.0000 0.0000
U.10 1,450 0.0000 4,749 0.0000 0.0000 U.49 991 0.0011 5,831 0.0000 0.0000
U.12 627 0.6874 1,336 0.0632 0.0000 U.50 1,407 0.0000 7,546 0.0000 0.0000
U.15 726 0.2105 2,716 0.0000 0.0004 U.51 560 0.8286 3,750 0.0000 0.0000
U.16 389 0.2914 2,054 0.0000 0.0000 U.52 628 0.8284 1,731 0.0000 0.0000
U.18 367 0.1240 4,042 0.0000 0.0000 U.54 676 0.2346 3,561 0.0000 0.0000
U.19X 435 0.4021 9,223 0.0000 0.0000 U.55 574 0.4009 2,437 0.0000 0.0000
U.21 353 0.2004 1,801 0.0000 0.0000 U.56 505 0.3837 1,455 0.0039 0.0000
U.22 421 0.5772 2,767 0.0000 0.0001 R.Fd 663 1.0000 843 0.4187 0.3183
U.23 1,984 0.0156 6,349 0.0000 0.0000 R.4 8,205 0.0000 2,930 0.0000 0.0000
U.24 1,043 0.0218 3,919 0.0000 0.0014 S.1 17,194 0.0000 15,490 0.0000 0.8045
U.25 373 0.2769 3,586 0.0000 0.0000 S.2 650 0.7100 4,664 0.0000 0.0000
U.27 2,098 0.0345 6,367 0.0000 0.0030 S.3 1,166 0.0103 5,010 0.0000 0.0000
U.29 3,030 0.0000 3,729 0.0000 0.9753 S.5 2,287 0.0000 9,329 0.0000 0.0002
U.30 1,812 0.0000 1,051 0.0395 0.6198 S.8 3,623 0.0000 9,464 0.0000 0.0761
U.31 2,211 0.0000 3,616 0.0000 0.0010 S.12 6,451 0.0000 8,189 0.0000 0.7568
a Signal intensities were determined by calculating the median of background-subtracted values for three independent experiments based on 9 or 18 replicates. P
values reported with corresponding median values (Rank) were determined by ranking the replicate values for each sequence (n 5 9 or 18) from both mock- and
HSV-infected cells. The null hypothesis, that mock and HSV groups are identical, was tested for the ranked values instead of the background adjusted values by using
Student’s t test with two-tail distribution and assuming unequal variance. This procedure of applying Student’s t test to the rank of the signals instead the signal values
is an approximation to the nonparametric Mann-Whitney rank test (16). Boldface entries are comparable or increased in 27lacZ (an insertion mutant expressing a
chimeric transcript [40, 49, 52]) infection compared to wt KOS infection.
b The null hypothesis is that the mutant (27lacZ) and wt signals are the same.
c Signal too low under conditions used for a meaningful conclusion.
d P , 0.0001.
TABLE 3. Effect of the host cell on the ratio of HSV-1 transcripts
at early and late times following infection
8-h/2-h signal,
HeLa cells
Probe
set
7-h/3-h signal,
rabbit skin
cells
8-h/2-h signal,
HeLa cells
Probe
set
7-h/3-h signal,
rabbit skin
cells
0.75 R.A 0.67 2.28 U.35 0.60
1.80 R.O 1.00 9.21 U.36 1.09
2.64 R.C 0.78 6.34 U.37 1.13
4.47 R.D 1.39 23.10 U.38 2.46
5.80 R.E 1.51 0.79 U.39 0.55
1.08 U.1 0.80 4.77 U.41 1.30
0.90 U.1X 0.15 2.90 U.42 1.54
2.74 U.3 3.93 3.25 U.43 2.85
3.78 U.4 1.16 10.38 U.44 1.80
5.56 U.6 1.09 0.91 U.46 0.91
4.51 U.8 0.52 1.73 U.48 0.64
5.46 U.10 1.88 1.81 U.49 0.73
0.51 U.12 0.66 1.45 U.50 0.85
3.35 U.15 1.14 14.40 U.51 2.02
5.10 U.16 2.06 3.51 U.52 1.04
3.19 U.18 1.91 0.41 U.54 0.46
0.74 U.19X 1.79 2.19 U.55 0.53
2.04 U.21 2.20 1.59 U.56 0.61
1.71 U.22 1.54 3.52 R.F 2.14
0.39 U.23 1.47 4.48 R.4 0.59
3.27 U.24 2.80 0.80 S.1 0.73
1.85 U.25 3.08 1.41 S.2 1.52
0.73 U.27 1.64 0.68 S.3 0.87
1.26 U.29 0.94 0.68 S.5 1.48
0.49 U.30 0.44 0.54 S.8 1.96
5.41 U.31 3.16 0.73 S.12 1.51
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infected cell to uninfected cell abundance is shown graphically
in Fig. 4A. Notably, against (an expected) general decline in
cellular mRNA abundance, transcripts representing database
entries ATF3, INFa/b, ISG 54K E2, JUNC, N-SHC, and TAP1
were present at levels near or above control values at either the
2- or 8-h time point.
The effect of infection of the 27lacZ mutant on cellular
transcript abundance was more varied (Table 5 and Fig. 4B).
The major decline in transcript abundance is not seen at 6 h
following infection with this mutant, but some transcripts are
markedly reduced compared to control values. These include
CYCLIND1, IL6, JUNC, MHC-2, p107, p130 HSP130K, and
RARb. Transcripts specific for INFa/b, JUNBta, JUND, N-
SHC, p15, p16, p27, and TAP1 were significantly increased in
abundance compared to control values.
DISCUSSION
The data presented here demonstrate the power of the ap-
proach of using defined oligonucleotide probes for the HSV-1
DNA microarray. Such a microarray provides an additional
convenient addition to the available tools for the investigation
of HSV transcription. Our immediate goal was to construct a
microarray with the minimum number of probes necessary to
uniquely detect all groups of HSV transcripts as well as diag-
nostic host cell genes perturbed by viral infection. Our criteria
for choosing appropriate probes included position relative to
the transcript polyadenylation site, lack of internal repeat or
reiterated sequences, and base composition near the average
for the region of DNA being transcribed. The first-generation
chip that we have constructed demonstrates that these criteria
are sufficient for the choice of probes displaying excellent spec-
FIG. 3. The log10 of the ratio of late to early infected HeLa and rabbit skin cell viral RNA is plotted to emphasize time-specific differences in abundance. The late
and early times for HeLa cells are 8 and 2 h p.i., respectively; those for rabbit skin cells are 7 and 3 h p.i.
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ificity and adequate sensitivity for assaying the expression of a
large number of viral genes under various conditions of infec-
tion. Despite its value, however, it is important to note that
further probes and cDNA synthesis regimens will be necessary
to fully optimize the specificity of detection of individual viral
genes transcribed. Our ultimate goal is to apply this microarray
technology to direct analysis of viral gene expression in specific
tissues and in animals.
Since the general patterns of HSV-1 gene expression during
productive infection are well known, as is the transcription
program and relationship of transcripts to genomic sequence,
we used viral RNA isolated under varied conditions of infec-
tion to serve as our basic platform for assaying the capabilities
of the present microarray for detailed global analysis of viral
transcript abundance.
Microarray analysis of HSV mRNA abundance. General
patterns of viral gene expression and gene function have been
derived from studies where relatively large quantities of cul-
tured cells are infected under selected and/or optimized con-
ditions (see references 53 and 55 for recent reviews emphasiz-
ing our own point of view on this broadly studied topic). The
summary microarray data presented in Table 2 are in good
general agreement with the far more laboriously formulated
kinetic classification of viral transcripts based on Northern
blot, hybrid selection, RNase protection, primer extension, and
metabolic labeling studies carried out over the past two de-
cades. There are, of course, some areas of nonagreement.
Some of these are due to lack of resolution of the current chip,
since coterminal transcripts of different kinetic classes cannot
be distinguished. Also, and not surprisingly, some discrepan-
cies are seen with transcripts expressed with low abundance.
And it is clear that the actual cell in which the studies are
carried out has a significant bearing on the relative proportion
of viral transcripts recovered at any given time or under any
particular conditions of infection. Thus, HeLa cells require
quite high levels of cycloheximide (100 mg/ml) to suppress
low-level expression of one or two nominally early HSV tran-
scripts. Also, the early UL37 transcript continues to accumu-
late late in infected HeLa cells but not rabbit skin cells (Table
3). Another example can be seen in the level of the prototyp-
ical immediate-early a4 transcript, which does not change
much between 2 and 8 h in HeLa cells but decreases markedly
in rabbit skin cells (compare Tables 2 and 3). While most
differences in accumulation can be ascribed to differential
mRNA stability in the various cells infected with the virus,
other differences may reflect differences in the efficiency of
shutoff of early transcription at late times in various cell types.
Indeed, the sharp shutoff with rabbit skin cells is the major
reason that we have used them for our continuing kinetic
studies (62).
Most of these relatively few discrepancies will be readily
resolved by increasing the resolution of the microarray using
random oligomers as well as oligo(dT) to prime cDNA synthe-
sis and by carefully characterizing the nature of viral transcrip-
tion and RNA accumulation as a function of the cell infected.
Some discrepancies, however, are the result of inadequacies in
our current kinetic classification schemes. The classification of
three basic groups of transcripts (and the proteins encoded by
them) is based on one or another measures of transcript abun-
dance in infections where virus-induced protein and DNA syn-
thesis are blocked with metabolic inhibitors. The subclassifica-
tion into leaky late and strict late, early and delayed early, etc.,
is based on relative abundance at specific times before and
after genome replication. Such a scheme fails to take into
account the real situation where some transcripts are expressed
at low levels throughout infection and neither amplified nor
shut off. This would appear to be the case for LAT (latency-
associated transcript) and its truncated 59-colinear polyadenyl-
ated transcript detected by probe sets R.C and R.F, respec-
tively. Further, the levels of others transcripts are modulated
posttranscriptionally. Other variations are also evident. For
example, expression of the ICP34.5 protein has been classified
as strict late (essentially requiring viral genome replication for
expression), yet our experiments demonstrate that the tran-
TABLE 5. Relative abundance of transcripts under various
conditions of HSV-1 infection of HeLa cells
Cell
transcript
Ratio, infected cell/uninfected cell transcript abundancea
0 h p.i. 2 h p.i. 6 h p.i.,KOS 8 h p.i.
6 h p.i.,
27lacZ
ATF3 2.23 1.66 2.09 1.71 1.80
CCNA cyclinA 1.60 0.37 0.23 0.22 1.55
CvDC25A 1.61 0.32 0.32 0.38 1.07
CvDC25B 1.44 0.39 0.18 0.28 1.98
CYCLIN B 2.07 0.33 0.21 0.39 1.47
CYCLIND1 2.62 0.11 0.13 0.19 0.97
E2F1 1.70 0.33 0.24 0.24 1.23
E2F2 1.80 0.90 1.50 0.37 1.90
E2F5 2.38 0.30 0.41 0.45 2.05
ELK 1.85 0.34 0.46 0.38 2.05
FAS-1A 1.63 0.24 0.29 0.25 1.56
FAS-2 2.23 0.37 0.45 0.41 1.77
FOS 1.64 0.16 0.21 0.32 1.21
FRA1 3.01 0.31 0.55 0.41 1.51
IL6 1.72 0.11 0.10 0.20 0.85
INF a/b 2.08 3.06 1.73 2.30 7.62
INT6 3.11 0.21 0.47 0.43 2.17
IRF1 2.14 0.25 0.88 0.37 1.87
ISG 54K E1 1.94 1.69 1.29 0.65 2.89
ISG 54K E2 1.76 0.30 0.33 0.32 2.71
ISG F3g p48 2.11 0.44 1.16 0.62 2.32
JAK3 2.55 0.46 0.85 0.56 1.78
JNK 1.95 0.26 0.43 0.82 1.77
JUN B 2.55 0.39 0.54 0.62 2.30
JUNBta 2.30 0.44 0.58 0.60 4.09
JUNC 2.36 0.60 2.13 1.71 0.65
JUND 2.08 0.20 0.26 0.22 2.96
MAPK 2.20 0.25 0.36 0.35 1.64
MBP-2 1.57 0.46 0.64 0.33 1.99
MHC-1 2.23 0.47 0.43 0.30 1.55
MHC-2 1.31 0.60 0.25 0.45 0.69
mlkBa 2.83 0.21 0.72 0.51 1.92
NFAT1 1.90 0.28 0.33 0.59 1.73
NF-Y 1.61 0.15 0.16 0.27 1.25
NF-YB 1.80 0.13 0.18 0.26 1.27
N-SHC 1.16 1.67 1.00 3.03 2.56
p107 1.98 0.87 1.07 0.88 1.49
p130 HSP130K 1.90 0.14 0.12 0.21 0.99
p15 2.28 0.37 0.44 0.34 2.72
p16 2.80 0.16 0.46 0.39 2.40
p18 1.88 0.45 0.70 0.51 1.38
p19 1.90 0.19 0.33 0.53 1.52
p21 (PAK1) 2.00 0.39 1.19 0.71 2.31
p27 1.70 0.13 0.28 0.12 4.11
p300 2.47 0.27 0.27 0.12 1.22
p38 (RPP38) 2.18 0.28 0.32 0.45 1.88
p53 2.22 0.18 0.26 0.27 1.41
p65NFkB 2.36 1.26 1.27 0.90 2.26
RARa1 1.33 0.14 0.15 0.24 1.36
RARb 1.72 0.12 0.13 0.20 0.66
RXRb 1.70 0.45 0.22 0.24 1.21
SRF 2.19 0.50 0.92 0.98 2.59
STAT2 2.43 0.22 0.56 0.83 2.40
STAT5 1.85 1.33 2.79 1.29 2.06
STAT6 2.35 0.29 0.43 0.63 1.96
TAP1 1.84 1.78 4.72 0.99 3.12
UNG 1.94 0.13 0.10 0.17 1.01
a Based on at least two separate experiments.
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script encoding it detected by probe set R.A is present at
essentially equivalent levels at 2 h and 8 h. While the expres-
sion of this transcript is somewhat reduced in the presence of
the DNA replication inhibitor PAA, it clearly does not fit the
criteria of a strict-late transcript such as seen with UL38 and
UL44/45 detected by the U.38 and U.44 probe sets, respec-
tively.
Our survey of the relative abundance of viral transcripts
expressed during infection with the 27lacZ mutant virus, in
which the posttranscriptional regulatory protein a27 (UL54)
has been inactivated, provides an excellent example of some of
the advantages as well as limitations of using global quantita-
tive analysis to form a complete picture of the situation inside
the infected cell. Work from a number of laboratories has
consistently shown that this protein has a major role in post-
transcriptional regulation of viral RNA both through inhibition
of splicing and by mediating the transport of a subset of viral
transcripts from the nucleus to the cytoplasm in infected cells.
This observation is based on a comparison in various cell types
of the relative levels of a4, a0, a47 (US12), UL8 (helicase-
primase), UL19 (major capsid protein), UL23 (thymidine ki-
nase), UL24, UL27 (gB), UL29 (major DNA binding protein),
UL30 (DNA polymerase), UL38 (capsid protein), UL41 (viri-
on-associated shutoff protein), UL44 (gC), UL52 (helicase-pri-
mase), US6 (gD), and US11 (RNA binding protein) on polyri-
bosomes as well as the ratio of viral transcripts in the nucleus
versus the cytoplasm (18–21, 34–36, 41, 52). While we will need
to use polysome-associated and nuclear and cytoplasmic RNA
fractions for a complete comparison, generally the results of
these studies are consistent with those presented in Table 4.
Thus, increases in the levels of a4 and a47 (US12) were evident
(19–21). Despite this overall consistency, we did not see the
marked reduction in levels of UL30 (DNA polymerase) and
UL52 (helicase-primase) transcripts reported (52). Also, DNA
microarray analysis demonstrated an increased signal using the
U.38 probe set specific for the UL38 transcript in contrast to
the complete absence of full-length transcript on polyribo-
somes noted by Hibbard and Sandri-Goldin (21). In other
work, however, these same workers found that 39 probes spe-
cific for UL38 mRNA detected a 0.4-kb transcript in 27lacZ-
infected cells, while 59 probes detected nothing (M. K. Hibbard
and R. M. Sandri-Goldin, unpublished data). Such a result
suggests the stable accumulation of a misprocessed form of this
transcript in mutant-infected cells. Such stable RNA fragments
may also account, in part, for the other discrepancies noted
here.
While it is clear that greater probe resolution and RNA
fractionation will be required to fully characterize the specific
transcripts accumulating during infections with mutants lack-
ing functional a27 (UL54) protein using DNA microarray tech-
nology, the resolution of the present chip is still sufficient to
add new information. Thus, the accumulation of the a4 and
FIG. 4. Abundance of selected cellular transcripts under various conditions
of HSV-1 infection of HeLa cells. The relative abundance of transcripts hybrid-
izing to the cellular probes used in this study is shown in Table 5. The log10 of the
ratio of the signal seen in mock-infected to infected cells is plotted here. (A)
Relative levels of cellular transcripts present under various conditions of infec-
tion with the 17syn1 strain of HSV-1. The dashed line is the average ratio of
mock-infected to infected cell signal for RNA isolated immediately following a
30-min virus adsorption period (top). (B) Effect of the a27 (UL54) immediate-
early protein on cellular RNA abundance. The dashed line shows the average
values of the 0-h control in panel A. The top panel shows the ratio of abundance
of cellular RNAs in HeLa cells 6 h following infection and mock infection with
the 27lacZ mutant of the KOS strain of HSV-1; the bottom panel shows the same
ratio for cells infected and mock infected with the wt parental KOS strain.
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a47 (US12) transcripts is reflected by a similar increase in the
level of a22 (US1) mRNA (Table 5). This suggests that the a27
(UL54) protein may play a role in modulating levels of these
immediate-early transcripts during the normal course of infec-
tion. The increase in abundance of transcripts detected by the
U.30 and U.39 probe sets suggests important roles for them at
the earliest stages of infection, and their apparent refractori-
ness to inhibition of protein synthesis in HeLa cells may be a
related phenomenon. The statistically significant decrease in
the abundance of ICP34.5 as seen with the loss of material
hybridizing to probe set R.A suggests that the a27 protein also
modulates the expression of this neurovirulence factor.
HSV-1 infection augments the abundance of some cellular
transcripts. Hobbs and DeLuca (22), using an HSV mutant
expressing primarily ICP0 and a human DNA microarray,
noted induction of cellular transcripts. A similar array specific
for 327 cellular genes was recently used to assess the effect of
wt HSV infection in human embryonic lung cells (25). In agree-
ment with these surveys, our much less extensive survey of
cellular genes shown in Table 5 and Fig. 3A reveals a marked
general decrease in transcript abundance. Exceptions include a
limited number of stress response and cellular transcriptional
regulatory genes. None of the transcripts surveyed were in-
cluded in our group of cellular probes, but it is notable that the
transcription factor ATF4 transcript abundance was increased
since we found this to also be the case for the ATF3-specific
transcript. In our studies, the INFa/b probe showed the most
striking increase in cellular transcript abundance, and we also
found increases in ISG 54K E2, JUNC, N-SHC, STAT5, and
TAP1 transcripts consistent with a major effect on a limited
number of stress response and regulatory genes.
A role of the a27 (UL54) protein in the shutoff of host cell
protein synthesis has been inferred from studies of protein
synthesis in mutant virus-infected cells (36, 39, 50). Our anal-
ysis adds significant dimension to that picture by showing that
the protein is directly involved in a decline in host mRNA
abundance. Despite the general lack of decline of host cell
transcripts, no correlation with extensive splicing was noted,
and several were clearly reduced during infection with the
regulatory mutant. Reductions in the levels of MHC (major
histocompatibility complex) class II may reflect a role of a47
(US12) protein, although its primary function appears to be in
the MHC class I pathway (17). Decreases in CYCLIND1, IL6,
JUNC, p107, p130, HSP130K, and RARb transcripts must
reflect the specific function(s) of other viral genes.
When adjusted for the appropriate controls, the abundance
of only a few cellular transcripts increased during infection
with the mutant virus. While similar to those increased in wt
infections, the set was not identical. These results suggest that
the a27 (UL54) protein plays a role in the induction or stabi-
lization of specific cellular genes following infection. This role
may be related to its differential effect on the abundance and
stability of only a subset of viral transcripts. It will be of interest
to determine whether such transcripts contain common struc-
tural motifs.
Conclusions. As useful as the application of DNA microar-
ray analysis is and will continue to be in studying viral gene
expression in cultured cells, such infection does not necessarily
reflect the process of virus infection and spread in the host.
The most promising application of HSV-specific chips will be
in analysis of viral replication in reactivation from latent infec-
tion and infection of a specific organ or cell type. Further,
techniques are now available for collection of individual neu-
rons and laser dissection of individual cells or extremely small
samples of differentiated tissue and for the amplification of
RNA in such tissues (14, 28, 43, 44, 46, 51). The power of the
approach will be augmented by assaying an increasing collec-
tion of cellular genes (both human and those specific for the
animal model being studied) chosen to represent those whose
expression is modulated by the stress of viral infection. The
broad patterns of HSV and critical cellular gene expression
exhibited under various conditions of infection and under the
influence of defined modification of critical regulatory genes
will illuminate potential critical points in the course of virus
replication in the whole animal. Those differentiated cells and
tissues where there is a critical restriction of virus replication
are precisely the points where it can be expected that the full
panoply of viral regulatory circuits must operate to optimum
effect. They will provide important experimental subjects for
further regulatory studies.
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